Antimicrobial Agents and Chemotherapy · 2020 · 30 citations · 24 references
MedicinePharmacokineticsPharmacologyAntimicrobial PharmacologyAntimicrobial PharmacotherapyMedical MicrobiologyAntibacterial PharmacologyAntibiotic ResistanceAntimicrobial DosingAntimicrobial PharmacodynamicsDefinitive Antimicrobial TherapyPharmacokinetics Of AntimicrobialsAntibiotic PharmacodynamicsBeta-lactam PharmacodynamicsFree FractionMinimum Inhibitory Concentration - Based DosingPseudomonas Aeruginosa Infection TreatmentTime Above Minimum Inhibitory ConcentrationTime-kill Kineticsβ-Lactam Antibiotics
Pseudomonas aeruginosa bacteremia is an infection associated with a high mortality rate. Piperacillin-tazobactam is a β-lactam–β-lactamase inhibitor combination that is frequently used for the management of Pseudomonas aeruginosa infections. The pharmacokinetic-pharmacodynamic index associated with in vitro maximal bacterial killing for piperacillin-tazobactam is the percentage of the time between doses at which the free fraction concentration remains above the MIC (% fT >MIC ).
24
Choice Reviews Online · 1990 · 35.7K citations
William A. Knaus, Elizabeth A. Draper, Douglas P. Wagner et al. · Critical Care Medicine · 1985 · 13.7K citations
Medicine, Internal Medicine, Clinical Classification Systems +16
APACHE II: a severity of disease classification system.
Elizabeth S. Draper · PubMed · 1985 · 6.1K citations
Hilmar Wisplinghoff, Thomas Bischoff, Sandra Tallent et al. · Clinical Infectious Diseases · 2004 · 4.5K citations · Full text
Veterinary Medicine, Infectious Disease Control, Infectious Diseases +16